Literature DB >> 33106988

Bacillus sonorensis L. Asparaginase: Cloning, Expression in E. coli and Characterization.

Nihal Aly1, Amani El-Ahwany1, Farid Shokry Ataya2,3, Hesham Saeed4.   

Abstract

L-asparaginases (L-ASNases; EC 3.5.1.1) are aminohydrolases that catalyze the hydrolysis of L-asparagine (L-Asn) to L-aspartic acid and ammonia, resulting in the death of acute lymphoblastic leukemic cells and other blood cancer cells. In this study, Bacillus sonorensis (accession number MK523484) uncharacterized L-ASNase gene (accession number MN562875) was isolated by polymerase chain reaction (PCR), cloned into pET28a (+) vector, and expressed in Escherichia coli as a cytosolic protein. The recombinant enzyme was purified by affinity chromatography at 23.79-fold and 49.37% recovery. Denaturing polyacrylamide gel (10%) analysis of the purified enzyme resulted in a single protein band at 36 kDa that immunoreacted strongly with 6His-tag monoclonal antibody. The purified enzyme exhibited optimal activity at 45 °C and pH 7.0 and retained 92% and 85% of its initial activity after incubation for 60 min at 37 °C and 45 °C, respectively. The purified enzyme exhibited substrate specificity toward L-asparagine and low glutaminase activity (15.72%) toward L-glutamine at a concentration of 10 mM. The Km and Vmax values were 2.004 mM and 3723 µmol min1-, respectively.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Bacillus sonorensis; Cloning; Recombinant protein

Year:  2020        PMID: 33106988     DOI: 10.1007/s10930-020-09932-x

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  37 in total

1.  The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.

Authors:  Wai Kin Chan; Philip L Lorenzi; Andriy Anishkin; Preeti Purwaha; David M Rogers; Sergei Sukharev; Susan B Rempe; John N Weinstein
Journal:  Blood       Date:  2014-03-21       Impact factor: 22.113

2.  Expression and Functional Characterization of Pseudomonas aeruginosa Recombinant L.Asparaginase.

Authors:  Hesham Saeed; Hadeer Soudan; Amany El-Sharkawy; Aida Farag; Amira Embaby; Farid Ataya
Journal:  Protein J       Date:  2018-10       Impact factor: 2.371

3.  L-asparaginase: inhibition of endogenous RNA polymerase activity in regenerating liver.

Authors:  F F Becker; J D Broome
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

4.  Asymmetrical flow field-flow fractionation for the analysis of PEG-asparaginase.

Authors:  C John; T Herz; J Boos; K Langer; G Hempel
Journal:  Talanta       Date:  2015-08-29       Impact factor: 6.057

5.  Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.

Authors:  Douglas S Hawkins; Julie R Park; Blythe G Thomson; Judy L Felgenhauer; John S Holcenberg; Eduard H Panosyan; Vassilios I Avramis
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

6.  Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects.

Authors:  G Ollenschläger; E Roth; W Linkesch; S Jansen; A Simmel; B Mödder
Journal:  Eur J Clin Invest       Date:  1988-10       Impact factor: 4.686

7.  Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).

Authors:  Eduard H Panosyan; Rita S Grigoryan; Ioannis A Avramis; Nita L Seibel; Paul S Gaynon; Stuart E Siegel; Howard J Fingert; Vassilios I Avramis
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

8.  A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.

Authors:  Hien Anh Nguyen; Ying Su; Jenny Y Zhang; Aleksandar Antanasijevic; Michael Caffrey; Amanda M Schalk; Li Liu; Damiano Rondelli; Annie Oh; Dolores L Mahmud; Maarten C Bosland; Andre Kajdacsy-Balla; Sofie Peirs; Tim Lammens; Veerle Mondelaers; Barbara De Moerloose; Steven Goossens; Michael J Schlicht; Kasim K Kabirov; Alexander V Lyubimov; Bradley J Merrill; Yogen Saunthararajah; Pieter Van Vlierberghe; Arnon Lavie
Journal:  Cancer Res       Date:  2018-01-17       Impact factor: 12.701

Review 9.  Asparaginase pharmacokinetics and implications of therapeutic drug monitoring.

Authors:  Barbara Asselin; Carmelo Rizzari
Journal:  Leuk Lymphoma       Date:  2015-03-11

Review 10.  Current applications and different approaches for microbial l-asparaginase production.

Authors:  Jorge Javier Muso Cachumba; Felipe Antonio Fernandes Antunes; Guilherme Fernando Dias Peres; Larissa Pereira Brumano; Júlio César Dos Santos; Silvio Silvério Da Silva
Journal:  Braz J Microbiol       Date:  2016-10-27       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.